Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Evaluating new vaccines for developing countries. Efficacy or effectiveness?

Clemens J, Brenner R, Rao M, Tafari N, Lowe C.

JAMA. 1996 Feb 7;275(5):390-7.

PMID:
8569019
2.
3.

Evaluation of vaccines against enteric infections: a clinical and public health research agenda for developing countries.

Clemens J.

Philos Trans R Soc Lond B Biol Sci. 2011 Oct 12;366(1579):2799-805. doi: 10.1098/rstb.2011.0033. Review.

4.

Issues in the design and implementation of vaccine trials in less developed countries.

Deen JL, Clemens JD.

Nat Rev Drug Discov. 2006 Nov;5(11):932-40. Review.

PMID:
17080029
5.

Measuring protection: efficacy versus effectiveness.

Fedson DS.

Dev Biol Stand. 1998;95:195-201. Review.

PMID:
9855432
6.

Measurement of malaria vaccine efficacy in phase III trials: report of a WHO consultation.

Moorthy V, Reed Z, Smith PG; WHO Study Group on Measures of Malaria Vaccine Efficacy.

Vaccine. 2007 Jul 9;25(28):5115-23. Epub 2007 Feb 2.

PMID:
17577487
7.
8.

Combining vitamin A and vaccines: convenience or conflict?

Benn CS.

Dan Med J. 2012 Jan;59(1):B4378. Review.

PMID:
22239846
9.

Efficacy and other milestones for human papillomavirus vaccine introduction.

Pagliusi SR, Teresa Aguado M.

Vaccine. 2004 Dec 16;23(5):569-78. Review.

PMID:
15630792
11.

Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.

Patel MM, Parashar UD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S291-9. doi: 10.1086/605059. Review.

12.

Vaccines and global health.

Greenwood B, Salisbury D, Hill AV.

Philos Trans R Soc Lond B Biol Sci. 2011 Oct 12;366(1579):2733-42. doi: 10.1098/rstb.2011.0076.

13.

Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.

Peny JM, Gleizes O, Covilard JP.

Vaccine. 2005 Aug 31;23(37):4610-8.

PMID:
15979769
14.

Veterinary and human vaccine evaluation methods.

Knight-Jones TJ, Edmond K, Gubbins S, Paton DJ.

Proc Biol Sci. 2014 Apr 16;281(1784):20132839. doi: 10.1098/rspb.2013.2839. Print 2014 Jun 7. Review.

15.

New approaches to the assessment of vaccine herd protection in clinical trials.

Clemens J, Shin S, Ali M.

Lancet Infect Dis. 2011 Jun;11(6):482-7. doi: 10.1016/S1473-3099(10)70318-2. Review.

PMID:
21616458
16.

Impact, challenges, and future projections of vaccine trials in Africa.

Idoko OT, Kochhar S, Agbenyega TE, Ogutu B, Ota MO.

Am J Trop Med Hyg. 2013 Mar;88(3):414-9. doi: 10.4269/ajtmh.12-0576. Review.

17.

Biological challenges to effective vaccines in the developing world.

Grassly NC, Kang G, Kampmann B.

Philos Trans R Soc Lond B Biol Sci. 2015 Jun 19;370(1671). pii: 20140138. doi: 10.1098/rstb.2014.0138.

18.

[Clinical effectiveness and economical evaluation of preventive vaccination].

Vaz Carneiro A, Belo AI, Gouveia M, Costa J, Borges M.

Acta Med Port. 2011 Jul-Aug;24(4):565-86. Epub 2011 Dec 12. Review. Portuguese.

19.

Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review.

Ozawa S, Mirelman A, Stack ML, Walker DG, Levine OS.

Vaccine. 2012 Dec 17;31(1):96-108. doi: 10.1016/j.vaccine.2012.10.103. Epub 2012 Nov 8. Review.

PMID:
23142307
20.

Study designs for evaluating different efficacy and effectiveness aspects of vaccines.

Halloran ME, Struchiner CJ, Longini IM Jr.

Am J Epidemiol. 1997 Nov 15;146(10):789-803. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk